InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Lundberg Jan M, 董事. Insider active across 2 companies, notably Ardelyx, INC.. Cumulatively, 6 disclosures have been logged. Activity tracked since 16 June 2021. The latest transaction was disclosed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lundberg Jan M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
12,755 股0Common StockSEC:0001628280-23-022559:0
91,240 股0Common StockSEC:0001567619-22-013083:0
7,181 股0Common StockSEC:0001567619-21-012427:0
15,541 股Common StockSEC:0000059478-16-000300:0
7,308 股Common StockSEC:0000059478-16-000300:1
29,081 股Common StockSEC:0000059478-16-000271:0
6 条申报中的 6 条
About Lundberg Jan M
Jan M. Lundberg is a Director of ARDELYX, INC. In this role, he participates in the governance of the company and strategic direction. ARDELYX, INC. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. Jan brings valuable expertise in leadership and strategy.
